Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19

Here we report on the humoral and cellular immune response in eight volunteers who autonomously chose to adhere to the Italian national COVID-19 vaccination campaign more than 3 months after receiving a single-administration GRAd-COV2 vaccine candidate in the context of the phase-1 clinical trial. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrati, Chiara, Capone, Stefania, Castilletti, Concetta, Cimini, Eleonora, Matusali, Giulia, Meschi, Silvia, Tartaglia, Eleonora, Camerini, Roberto, Lanini, Simone, Milleri, Stefano, Colloca, Stefano, Vitelli, Alessandra, Folgori, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569156/
https://www.ncbi.nlm.nih.gov/pubmed/34737309
http://dx.doi.org/10.1038/s41541-021-00394-5

Ejemplares similares

Ejemplares similares